Condition: End Stage Renal Disease · Sponsor: Fresenius Medical Care Deutschland GmbH
The SODIAH study is designed with the aim to assess the impact of isonatremic dialysis on interdialytic weight gain, fluid status, intradialytic hemodynamic stability, and incidence of intradialytic morbid events in dialysis patients. The study will be comparing the Na management option on the 6008 HD dialysis machines with the same machine without the Na management option turned on. Relevant performance and clinical data will be collected as well as information on patients' quality of life and wellbeing.
This description comes directly from the study's public registry record.
Jennifer Braun, Dr. · +49 6172 608 93488 · Jennifer.Braun@freseniusmedicalcare.com
Manuela Stauss-Grabo, Dr. · +4961726085248 · Manuela.Stauss-Grabo1@freseniusmedicalcare.com
Always discuss trial participation with your own doctor first.
| Fresenius Medical Care- DS, s.r.o. | Mariánské Lázně, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06341452